Childhood cancers trials in Greece
30 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Where
- Athens, Chaïdári, Ioannina
- Age
- 12 years and over
- People
- 340 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00 - Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Athens, Thessaloniki
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 3Taking peopleA Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
- Where
- Asvestochóri, Cholargós
- People
- 200 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05862285 · EU 2023-504263-16-00 - Phase 2/3Taking peopleLong-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Where
- Athens, Patras
- People
- 1,541 worldwide
- Run by
- Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00 - No phaseNot yet taking people in GreeceAssessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate
- Where
- Pátrai, Thessaloniki
- People
- 50 worldwide
- Run by
- Aristotle University Of Thessaloniki
See details and how to joinNCT07888322 - Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Athens
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - Phase 3Taking peopleBiological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
- Where
- Athens, Marousi
- Age
- 6 months and over
- People
- 433 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05476939 · EU 2023-506027-29-00 - Phase 3Taking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Chaïdári, Larissa, Patras
- Age
- 12 years and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - Phase 3Taking peopleInternational Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- Where
- Athens, Heraklion, Marousi, Thessaloniki
- Age
- Up to 64 years
- People
- 1,351 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501180-40-00 · EU 2022-501180-40-00 - Phase 3Taking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Athens, Heraklion, Marousi, Thessaloniki
- Age
- 1 day to 1 year
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - Phase 1/2Taking peopleA Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Where
- Athens
- Age
- 1 month to 17 years
- People
- 50 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06941272 · EU 2024-518771-66-00 - Phase 2Taking peopleStudy With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)
- Where
- Athens, Thessaloniki
- Age
- 0 months to 18 years
- People
- 95 worldwide
- Run by
- Helsinn Healthcare SA
See details and how to joinNCT06904235 - No phaseTaking peopleA Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
- Where
- Thessaloniki
- People
- 170 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT06423573 - Phase 2Taking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Athens
- Age
- 1 year to 17 years
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - Phase 3Taking peopleSIOP RANDOMET 2017
- Where
- Athens, Heraklion, Marousi, Thessaloniki
- Age
- Up to 17 years
- People
- 409 worldwide
- Run by
- GPOH gGmbH
See details and how to join2023-508926-91-00 · EU 2023-508926-91-00 - Phase 2/3Taking peopleAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Athens
- Age
- 1 month to 18 years
- People
- 1,800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - Phase 2Taking peopleStudy to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.
- Where
- Athens
- Age
- Up to 17 years
- People
- 16 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522138-29-00 · EU 2025-522138-29-00 - Phase 3Taking peopleVO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
- Where
- Athens, Efkarpia
- Age
- 12 years and over
- People
- 400 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06264180 · EU 2023-508612-29-00 - No phaseTaking peopleSPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
- Where
- Athens, Ioannina
- Age
- 12 years and over
- People
- 4,975 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT02834884 - No phaseTaking peopleDigital Support for Multiple Myeloma Quality of Life
- Where
- Athens
- People
- 108
- Run by
- CareAcross
See details and how to joinNCT07642362 - Phase 2/3Taking peopleSIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
- Where
- Athens, Heraklion, Marousi, Thessaloniki
- Age
- Up to 64 years
- People
- 894 worldwide
- Run by
- Centre Leon Berard
See details and how to joinNCT02265770 · EU 2024-512222-28-00 - Early phase 1Taking peopleCOLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer
- Where
- Thessaloniki
- People
- 12
- Run by
- Biogenea Pharmaceuticals Ltd.
See details and how to joinNCT07328087 - Early phase 1Enrolling by invitationGYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer
- Where
- Thessaloniki
- People
- 40
- Run by
- Biogenea Pharmaceuticals Ltd.
See details and how to joinNCT07316361 - Early phase 1Enrolling by invitationClinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer
- Where
- Thessaloniki
- People
- 90
- Run by
- Biogenea Pharmaceuticals Ltd.
See details and how to joinNCT07285434 - Phase 3Taking peopleHigh-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
- Where
- Athens, Heraklion, Marousi, Thessaloniki
- Age
- Up to 21 years
- People
- 800 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00